| Use of a proton pump inhibitor: Not more not less | Fatih TEKİN | 504–504 |
| NSAID, antiaggregant, and/or anticoagulant-related upper gastrointestinal bleeding: Is there any change in prophylaxis rate after a 10-year period? | Dinç DİNÇER,Ece ULUKAL KARANCI,Mete AKIN,Haydar ADANIR | 505–510 |
| Validity and reliability of the Quality of Life in Reflux and Dyspepsia (QoLRAD) questionnaire in patients with gastroesophageal reflux disease for the Turkish population | Sadık HANÇERLİOĞLU,Yasemin YILDIRIM,Serhat BOR | 511–516 |
| Distribution of nucleotide variants in the DNA sequence of ERCC1 and XRCC1 genes and the effect of phenotype in patients with gastric cancer | Elmir ASGEROV,Özgür ŞENOL,Adem GÜLER,Afig BERDELİ | 517–523 |
| Diagnostic accuracy of glycoproteins in the assessment of liver fibrosis: A comparison between laminin, fibronectin, and hyaluronic acid | Simin YOUNESI,Hadi PARSIAN | 524–531 |
| Model for end-stage liver disease and pneumonia: An improved scoring model for critically ill cirrhotic patients with pneumonia | Feng GAO,Meng Xing CAI,Miao Tong LIN,Ling Zhi ZHANG,Qian Zi RUAN,Zhi Ming HUANG | 532–540 |
| Assessing the characteristics and feasibility of preventing early mortality in patients with hepatocellular carcinoma | Masaaki WATANABE,Hiroaki YOKOMORI,Yoshihito TAKAHASHI,Takemichi OKADA,Akitaka SHIBUYA,Wasaburo KOIZUMI | 541–548 |
| Diagnostic value of blue laser imaging combined with magnifying endoscopy for precancerous and early gastric cancer lesions | Yang ZHENMING,Shen LEI | 549–556 |
| Protective effects of alendronate in Triton X-100-induced hyperlipidemia in rats | Ashiyana PARWIN,Abul Kalam NAJMI,Mohd Vasim ISMAIL,Madhu KAUNDAL,Mohd AKHTAR | 557–564 |
| A huge intra-abdominal hematoma with an unusual etiology | Yen Cheng CHEN,Hsiang Lin TSAI,Yung Sung YEH,Ching Wen HUANG,I Shu CHEN,Jaw Yuan WANG | 565–568 |
| Simultaneous osteosarcoma and adenocarcinoma of the gallbladder: A rare case report and literature review |